Existing research has confirmed that inhibiting protein translation is highly effective against myeloma, which aligns with our findings that suppressing METTL5 and its mediated protein translation effectively curbs MM progression [50, 51]. The gene discussed is METTL5; the disease is plasma cell myeloma.